Interleukin-1β triggers matrix metalloprotease-3 expression through p65/RelA activation in melanoma cells

Junichi Nunomura1, Rei Nakano1,2,3, Atsuto Naruke1

  • 1Laboratories of Veterinary Radiotherapy, Nihon University College of Bioresource Sciences, Fujisawa, Kanagawa, Japan.

Plos One
|November 29, 2022
PubMed

Insights

Interleukin-1β (IL-1β) increases matrix metalloprotease-3 (MMP-3) in canine melanoma cells, promoting tumor cell migration. This process involves the nuclear factor-kappa B (NF-κB) pathway, specifically p65/RelA activation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Veterinary Medicine

Background:

  • Melanoma is an aggressive skin cancer characterized by local invasion and metastasis.
  • Matrix metalloprotease-3 (MMP-3) degrades extracellular matrix components, facilitating tumor invasion and development.
  • Interleukin-1β (IL-1β) is a pro-inflammatory cytokine implicated in various cancers.

Purpose of the Study:

  • To investigate the role of IL-1β in regulating MMP-3 expression and canine melanoma cell migration.
  • To elucidate the signaling pathway involved in IL-1β-induced MMP-3 expression.

Main Methods:

  • Canine melanoma cells were treated with IL-1β.
  • MMP-3 expression and activity were measured using quantitative real-time PCR and enzyme activity assays.
  • Cell migration was assessed using a wound healing assay.
  • Inhibitors of MMP-3 (UK356618) and NF-κB (TPCA-1) were used.
  • Western blotting was performed to detect protein phosphorylation.
  • Gene silencing of NF-κB subunits (p65/RelA and p105) was conducted.

Main Results:

  • IL-1β treatment significantly increased MMP-3 mRNA expression and enzyme activity in canine melanoma cells.
  • IL-1β induced melanoma cell migration, which was reduced by MMP-3 inhibition.
  • NF-κB pathway activation, indicated by p65/RelA and p105 phosphorylation, was observed upon IL-1β treatment.
  • Inhibition of NF-κB signaling by TPCA-1 suppressed IL-1β-induced MMP-3 expression.
  • Depletion of p65/RelA, but not p105, abolished IL-1β-mediated MMP-3 mRNA upregulation.

Conclusions:

  • IL-1β stimulates MMP-3 expression and promotes migration in canine melanoma cells.
  • The IL-1β-induced MMP-3 expression is mediated through the activation of the NF-κB pathway, specifically involving the p65/RelA subunit.
  • Targeting the IL-1β/NF-κB/MMP-3 axis may represent a therapeutic strategy for canine melanoma.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.3K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K